Candidate risks indicators for bipolar disorder:early intervention opportunities in high-risk youth by Duffy, Anne et al.
Received: May 13, 2015; Revised: June 14, 2015; Accepted: June 16, 2015
© The Author 2015. Published by Oxford University Press on behalf of CINP.




This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, 
provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
review
Candidate Risks Indicators for Bipolar Disorder: Early 
Intervention Opportunities in High-Risk Youth
Anne Duffy, MD, MSc (Med Sci), FRCPC; Steven Jones, Msc (Clin Psych), PhD; 
Sarah Goodday, MSc (Comm Health); Richard Bentall, MA (Clin Psych),  
MA (Phil), PhD (Psych)
Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada (Dr Duffy); Mood Disorders Centre 
of Ottawa, Ottawa, Ontario, Canada (Dr Duffy); Lancaster University, Division of Health Research, Lancaster, 
United Kingdom (Dr Jones); Department of Epidemiology, Dalla Lana School of Public Health, University of 
Toronto, Toronto, Ontario, Canada (Ms Goodday, Dr Bentall); University of Liverpool, Institute of Psychology 
Health and Society, Liverpool, United Kingdom (Ms Goodday and Dr Bentall).
Correspondence: Anne Duffy, MD, MSc, FRCPC, Campus Alberta Innovates Chair in Youth Mental Health, Professor, Department of Psychiatry, University 
of Calgary, Alberta, Canada (acduffy@ucalgary.ca).
Abstract
Background: Psychiatric illnesses like bipolar disorder are increasingly understood to be neurodevelopmental disorders with 
clinical, psychological, and biological indicators recognizable long before the emergence of the full-blown syndromes.
Methods: This paper is a selective review of findings from studies of high-risk children of affected parents that inform the 
knowledge of illness risk and development markers of bipolar disorder. We specifically focus on candidate clinical, biological, 
and psychological risk indicators that could serve as targets for future early intervention and prevention studies.
Results: There is convergent evidence from prospective studies that bipolar disorder typically debuts as depressive episodes 
after puberty. In some high-risk children, sleep and anxiety disorders precede mood disorders by several years and reflect 
an increased vulnerability. An association between early exposure to adversity (eg, exposure to parental illness, neglect 
from mother) and increased risk of psychopathology may be mediated through increased stress reactivity evident at both 
behavioral and biological levels. Inter-related psychological processes including reward sensitivity, unstable self-esteem, 
rumination, and positive self-appraisal are risk factors for mood disorders. Disturbances in circadian rhythm and immune 
dysfunction are associated with mood disorders and may be vulnerability markers influenced by these other risk factors.
Conclusions: There is accruing evidence of a number of measurable and potentially modifiable markers of vulnerability and 
developing illness in youth at familial risk for bipolar disorder. Longitudinal studies of multiple biological and psychological 
risk processes in high-risk offspring, both individually and together, will improve our understanding of illness onset and lead 
to the development of specific early interventions.
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Introduction
Psychiatric disorders are increasingly being understood as herit-
able neurodevelopmental disorders with clinical manifestations 
occurring years prior to any recognizable diagnosable syn-
dromes (Insel, 2012). Adolescence is characterized by accelerated 
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biological, psychological, and social development and marks the 
beginning of the high-risk period for onset of mood disorders that 
recur into adulthood (Paus et al., 2008). Psychiatric illness during 
this important development period has devastating consequences 
that persist lifelong. Unipolar depression and bipolar disorder 
(BD) place among the top-ranked causes of morbidity and mor-
tality in youths aged 10 to 24 years (Gore et al., 2011). Moreover, 
other highly ranked causes of morbidity and mortality in this age 
group are associated with mood disorders (eg, addictions). Suicide 
is estimated to be the second leading cause of death in teens and 
young adults in Western countries, the majority of cases being 
associated with a psychiatric disorder (Cavanagh et al., 2003) and 
most often a mood disorder (Windfuhr et al., 2008).
Despite the substantial morbidity and mortality already evi-
dent early in the course of mood disorders, it reportedly takes 
over a decade from the time an individual seeks help until an 
accurate diagnosis is made and much longer still from the onset 
of impairing symptoms (Judd and Akiskal, 2003). Clearly there 
is an urgent need to identify serious mood disorders as early as 
possible and to develop effective and acceptable early interven-
tions. This paper provides an overview of the early natural his-
tory of BD and related mood disorders based on findings from 
selected prospective high-risk studies and highlights evidence 
for candidate early intervention targets including: antecedent 
risk syndromes, early adversity and attachment relationships, 
psychological processes, and circadian neuroendocrine and 
immune system disturbance. We close with a discussion of the 
implications for future clinical and research efforts.
Methods
This paper is intended as a selective review of an emerging field 
of increasing importance. There are limited published data to 
directly inform the question of risk indicators amenable to early 
intervention, and much systematic research remains to be com-
pleted. This selective review used perspectives from lead inves-
tigators, actively involved in longitudinal prospective research 
of offspring of bipolar parents, to describe the existing data on 
promising early intervention targets to inform this topic. Studies 
were selected based on the authors’ knowledge of the literature 
and supplemented through a MEDLINE search using the following 
combination of MeSH terms: high-risk, bipolar disorder, prospec-
tive, and longitudinal. We excluded neuroimaging studies in this 
review, as we felt this was beyond the scope of the manuscript.
Natural History and Clinical Staging
Evidence from a number of prospective studies has demon-
strated that, despite the high heritability of mood disorders, off-
spring of BD parents not uncommonly present with nonspecific 
psychiatric symptoms and syndromes early in childhood. This 
is true even in studies that controlled for assortative mating (ie, 
other parent well) and for socioeconomic effects (eg, isolated 
populations such as the Amish or Canadian middle class, intact 
families with accessible public healthcare). These early presen-
tations have included anxiety and sleep disturbances at both 
the symptom and syndrome level (Shaw, 2005; Duffy et al., 2013). 
Interestingly, the nature of these early-risk syndromes appears 
variable. For example, observed anxiety disorders in high-risk 
children include generalized, separation and social anxiety, 
panic disturbance, and phobia (Duffy et  al., 2013). However, 
obsessive compulsive and neurodevelopmental disorders are 
typically seen only in offspring of lithium nonresponsive par-
ents who suffer from a poorly remitting, psychotic subtype of BD 
(Duffy and Carlson, 2013; Duffy, 2014b).
With longer prospective study, it became evident that these 
earlier varied presentations in high-risk offspring were signaling 
vulnerability for mood disorders. Specifically, there is now con-
vergent evidence that high-risk offspring who manifest child-
hood anxiety and sleep disorders have a significantly elevated 
risk of developing major mood disorders (ie, depression, BD, 
schizoaffective-BD) in adolescence and early adulthood (Grof 
et al., 2009; Duffy et al., 2010; Nurnberger, 2011; Ritter et al., 2012). 
This raises several questions, including: (1) are these childhood 
risk syndromes an indicator of specific risk for mood disorder in 
an immature brain or an indicator of nonspecific vulnerability? 
(2) are there other indicators of mood disorder vulnerability in 
high-risk offspring at either or both the psychological and bio-
logical level? And (3) are these early presentations responsive 
to presumably relatively more benign and acceptable interven-
tions that subsequently change the distribution of BD severity 
and progression in the population (Scott et al., 2013).
Based on almost 20 years of longitudinal observation of well-
characterized BD parents divided into lithium-responsive subtypes 
and their family members, together with convergent findings from 
other longitudinal high-risk studies (Birmaher et al., 2009; Egeland 
et  al., 2012; Mesman et  al., 2013), Duffy and colleagues (2014) 
recently proposed a clinical staging model (Figure 1) describing the 
natural history of BD. This clinical staging model illustrates that in 
some high-risk offspring, early childhood risk syndromes transi-
tion into vulnerability to stress (adjustment disorders) and minor 
mood disorders during puberty. In mid- to late adolescence major 
depressive episodes onset, and typically several years later diag-
nosable activated episodes emerge (Duffy, 2014b, 2015; Duffy et al., 
2014). This model is not intended to capture all variability across 
individual cases of BD development but serves as an aggregate 
description based on several hundred prospectively followed off-
spring of parents systematically assessed and treated and largely 
suffering from Bipolar I Disorder (Duffy, 2014a). The model incorpo-
rates an important but neglected aspect of heterogeneity of BD by 
including 2 prototypical trajectories: lithium-responsive classical 
episodic illness and lithium nonresponsive psychotic spectrum BD 
(Duffy and Grof, 2001; Grof et al., 2009).
A developmental approach to understanding the emergence 
of psychiatric disorders is important to the aim of achieving 
earlier accurate identification of youth on a specific trajectory 
to develop a serious psychiatric illness. Furthermore, by taking 
into account the natural history of specific disorders, one can 
identify targeted and novel prevention and early intervention 
opportunities (McGorry et  al., 2010; Duffy and Carlson, 2013). 
To minimize false positives and over-diagnosis of normative or 
transient disturbance in youth, the proposed model limits the 
early clinical stages to youth at confirmed familial risk of BD, 
reflecting the high heritability of the disorder.
Promising Early Intervention Targets
Early Child Development
Mood disorders are complex and likely result from interplay 
between genetic, epigenetic, and environmental risk factors, 
which in turn predict psychological and biological vulnerability 
(Etain et al., 2008; Heim, 2012). Twin studies have established an 
independent effect of early environmental risk factors on mood 
disorder risk beyond genetic susceptibility (Kendler et al., 2000; 
Nelson et al., 2002; Silberg et al., 2010). From birth to approxi-
mately 7  years of age, children undergo major brain matura-
tion in critical regions related to emotional regulation and 
cognition (Paus et  al., 1999; Keverne, 2004). Stress during this 
critical time can have lasting negative effects through altera-
tions in brain structure and function (Murray et al., 2004). The 
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hypothalamic-pituitary-adrenal (HPA) axis, centrally important 
in the development of mood disorders, continues to develop for 
the first few months after birth and is especially vulnerable dur-
ing this time, while the presence of attachment relationships 
in the following months act to regulate HPA axis activity (Doom 
and Gunnar, 2013).
Reports of childhood abuse and neglect are commonly 
reported in some studies of adult patients with BD (Garno et al., 
2005). Evidence suggests that early childhood stressors may 
contribute to the substantial morbidity associated with BD. In 
particular, individuals with BD and a history of physical and sex-
ual abuse reportedly have an earlier age of onset (Daruy-Filho 
et  al., 2011), worsened clinical presentation and psychosocial 
functioning (Daglas et  al., 2014), higher rate of comorbid sub-
stance abuse (Garno et al., 2005), and a higher number of suicide 
attempts (Daruy-Filho et al., 2011). Experiencing emotional and 
sexual abuse may in part explain why certain individuals with 
BD express suicidal behavior while some do not (Etain et  al., 
2008). Although less studied, it has been reported that rates of 
BD are higher among high-risk children with a history of child-
hood abuse compared with those without (Goldstein et al., 2010).
Until recently, little attention has been paid to how having 
a parent with BD impacts risk of developing psychopathology 
beyond the genetic susceptibility. This is despite compelling evi-
dence of a significant association between exposure to paren-
tal unipolar depression in childhood and risk of mood disorder 
later in life (Fergusson et al., 1995; Hammen and Brennan, 2003; 
Murray et al., 2011; Naicker et al., 2012). Depending on the dura-
tion, severity, and timing of the illness episodes in the parents, 
children of an affected parent may be exposed to an irritable, 
agitated parent during a manic episode and a sad, distracted, 
and sometimes suicidal parent during a depressive episode. 
Furthermore, there may be emotional loss associated with 
parental separation either through divorce, hospitalization, 
or both.
In line with the observation of a critical period for HPA axis 
development and stress reactivity (Doom and Gunnar, 2013), we 
recently reported evidence that a higher exposure to parental 
BD during the first 2  years of life was significantly associated 
with the development of mood disorders in high-risk offspring 
(S. Goodday, A. Levy, G. Flowerdew, J. Horrocks, M. Ellenbogen, 
P. Grof, and A. Duffy, unpublished observations). A  higher 
duration of exposure to parental illness during the first decade 
of life was also significantly associated with the development of 
substance use disorders (Goodday, 2015). We have also reported 
that perceived neglect from mother was a significant predictor 
of mood disorder in high-risk offspring after taking into account 
the amount of exposure to parental BD during the first decade 
of life, life stress, and offspring temperament (Doucette et al., 
2014). Interestingly, other longitudinal studies of offspring of 
depressed mothers have reported similar findings, where poor 
support from the mother early in childhood was a significant 
predictor of unipolar depression later in life (Murray et al., 2011).
In addition to temperament, mechanisms underlying the 
association between early childhood adversity and development 
of BD have focused on disruptions in attachment and epigenetic 
mechanisms (Heim, 2012). Attachment relationships begin to 
formulate in the fourth to fifth months after birth, and evidence 
suggests that this relationship may have protective effects over 
HPA axis regulation (Doom and Gunnar, 2013). For example, even 
minor variations in maternal sensitivity during the first few 
months of life have been shown to significantly impact infant 
cortisol reactivity (Albers et al., 2008). Lack of expected nurtur-
ing from caregivers during this sensitive time may have last-
ing effects on the regulation of emotional systems (Doom and 
Gunnar, 2013). Findings on attachment style among offspring 
of BD parents have been mixed, although this may reflect dif-
ferences in study populations and methods. Specifically, high 
risk offspring of BD parents with minimal psychiatric comor-
bidity and higher socio-economic status show more similar 
attachment patterns to controls and to the general popula-
tion (Reichart et al., 2007; Doucette et al., 2013), while children 
from families of lower socio-economic status and higher rates 
of parental comorbid substance use and personality disorders 
have more negative attachment to parents (Chang et al., 2001; 
Romero et al., 2005).
Taken together, the findings suggest that early-life adversity, 
including exposure to parental psychopathology very early in 
life, mother-child interactions, and trauma such as abuse and 
neglect, plays a significant role in the risk of BD in those already 
at familial risk and may contribute to a worsened prognosis. 
These factors could be potential targets for earlier identifica-
tion of offspring at ultra-high risk for developing BD and related 
mood disorders and serve as preventive intervention targets.
Figure 1. The clinical trajectory into bipolar disorder (BD) in high-risk offspring studied prospectively. LiNR, offspring of lithium nonresponder. Adapted from Duffy (2015).
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Psychological Processes
There is an increasing awareness of the importance of psycho-
logical processes in relation to the development and course of 
BD. Understanding of such processes is relevant to both devel-
opment of comprehensive biopsychosocial models of BD and 
to the development and refinement of effective psychological 
therapies. We have shown that temperamental elevations in 
emotionality are associated with a greater risk of mood disor-
ders in children of a BD parent and that such emotionality is 
linked with duration of exposure to parental illness (Doucette 
et  al., 2013, 2014). Specific psychological processes implicated 
in BD, which might provide promising early intervention tar-
gets, include impulsivity, reward sensitivity, rumination, and 
cognitive style. Each of these processes is discussed briefly in 
turn below.
Impulsivity has been defined as “a predisposition toward 
rapid, unplanned reactions to internal or external stimuli with-
out regard to the negative consequences” (Moeller et al., 2001). 
There is evidence for elevated impulsivity in BD, on both self-
report and computerized assessments, across euthymic and 
manic phases in particular (Moeller et  al., 2001; Swann et  al., 
2003, 2009). Higher rates of impulsivity in BD are also associated 
with comorbid problems including substance use and suicidal-
ity (Swann et al., 2004, 2005). There have also been suggestions 
that impulsivity may be an early characteristic of developing 
psychopathology in young child offspring of BD parents (Fergus 
et al., 2003; Birmaher et al., 2010).
Research into reward sensitivity has developed from 3 com-
plimentary fields of investigation. First, there is evidence that 
dopamine, which is implicated in reward seeking and reward 
sensitivity (Wise and Rompre, 1989; Panksepp et al., 2002), can 
induce mania symptoms in both healthy controls and individu-
als with BD (Van Kammen and Murphy, 1975; Johanson and 
Uhlenhuth, 1980; Halbreich et al., 1981; Nurnberger et al., 1982; 
Sernyak and Woods, 1993). Second, research with BD patients 
suggests that goal attainment life events can trigger a manic epi-
sode (Johnson et al., 2000). Third, the behavioral activation sys-
tem, which governs individual approach behavior in response to 
signals of possible reward/goal attainment, has been theorized 
to play a key role in BD with respect to both mania and depres-
sion (Depue and Iacono, 1989; Depue et al., 1989; Urosevic et al., 
2008). It is worth noting that impulsivity and reward sensitivity 
are clearly inter-related phenomena. Individuals at behavioral 
risk of BD show preference for immediate rewards over delayed 
rewards, and on electroencephalography this bias is associated 
with greater differentiation between delayed and immediate 
outcomes in early attention-sensitive and later reward-sensitive 
(feedback-related negativity) components (Mason et al., 2012).
Prospective studies have shown that high-behavioral activa-
tion system sensitivity predicts greater likelihood of a BD spec-
trum diagnosis in the following year in college students (Alloy 
et al., 2012) as well as interacting with impulsiveness to predict 
academic attainment (Nusslock et  al., 2008) and both BD and 
substance use disorder onsets over a similar period (Alloy et al., 
2009). Additionally, in the presence of goal-striving events, indi-
viduals with BD, but not controls, exhibit increase manic but 
not depressive symptoms (Nusslock et al., 2007). In individuals 
with BD and those at risk, goals are regarded as more impor-
tant, set more ambitiously, and with greater perceived likelihood 
of success than in controls (Meyer and Krumm-Merabet, 2003; 
Meyer et al., 2004; Johnson et al., 2005; Johnson and Carver, 2006). 
Furthermore, there is recent fMRI evidence of disturbed reward 
processes in healthy offspring of a BD parent on a monetary 
incentive delay task compared with controls (Singh et al., 2014).
Rumination is indicated by repetitive patterns of thinking 
typically about negative affect or stressful events and inferences 
about their causes (Smith and Alloy, 2008). Rumination has been 
widely reported in unipolar depression both as a prospective 
risk factor for onset as well as predictive of worse outcomes in 
individuals with depression (Nolen-Hoeksema, 2000; Spasojevic 
and Alloy, 2001). There is also evidence that rumination is ele-
vated in individuals with BD even during remission (Jones et al., 
2006b; Thomas et al., 2007) and in individuals at behavioral risk 
(Knowles et al., 2005). This pattern of increased rumination has 
also been observed in teenage offspring of a BD parent (ie, who 
have not yet transitioned to BD) (Jones et al., 2006b; Pavlickova 
et  al., 2014). More recently, researchers have begun to investi-
gate positive rumination, described as repetitive thinking with 
respect to one’s own achievements and positive mood (Feldman 
et  al., 2008). Positive rumination is positively associated with 
behavioral risk for mania (Feldman et al., 2008) and is elevated 
in BD compared with unipolar depressed or control participants 
(Johnson et al., 2008).
Research into cognitive styles suggests evidence for unstable 
self-esteem and elevated positive self-appraisal in BD (Bentall 
et al., 2005; Jones et al., 2006a; Knowles et al., 2007). Prospectively, 
low explicit self-esteem appears to predict increased risk of 
both mania and depression in individuals diagnosed with BD 
(Pavlickova et al., 2013). We have also observed low and unsta-
ble explicit self-esteem in teenage offspring of bipolar parents 
(Jones et al., 2006b; Pavlickova et al., 2014). Although these phe-
nomena seem to be specifically associated with the presence of 
depressive symptoms (Pavlickova et al., 2015), there is some evi-
dence that manic symptoms in high-risk teenagers are associ-
ated with low implicit self-esteem (Pavlickova et al., 2014b).
The exploration of positive self-appraisal emerged from a 
model of BD that attempted to understand how circadian vul-
nerabilities (described below in 3)  might translate in the pat-
terns of symptoms and behavior observed in bipolar mood 
episodes (Jones, 2001). This proposed that mania symptoms in 
particular are more likely to occur when the individual applies a 
positive self-dispositional appraisal to experiences of significant 
circadian disturbance. This appraisal style has been observed in 
adults with BD (Jones et al., 2006a, 2006b) as well as in adoles-
cent and adult individuals at behavioral risk (Cooke and Jones, 
2009; Johnson and Jones, 2009) and has been associated with 
the extent to which positive experiences such as inspiration are 
linked to risk of mania (Jones et al., 2014). Regression analysis of 
the relative contributions of positive self-dispositional appraisal 
and familial risk in relation to mania risk in teenagers indicated 
that positive self-appraisal was the most significant predictor 
(Espie et al., 2012).
Taken overall, there is accumulating evidence for the impor-
tance of temperament, impulsivity, reward sensitivity, rumi-
nation, and self-appraisal processes in the development and 
recurrence of BD. It is therefore important to further evaluate 
the ability of markers of these processes to serve as predictors, 
separately and in combination, of risk for development of BD. In 
addition, structured psychological therapies have already been 
shown to have benefits in more recent onset BD (Scott et  al., 
2006; Jones et  al., 2015). Further refinement of such interven-
tions to better target these processes may improve the efficacy 
in BD and also provide options for preventative interventions in 
high-risk groups (Berk et al., 2007).
Circadian Neuroendocrine Immune Disturbances
Disruption in circadian rhythm is emerging as an important 
indicator of susceptibility to BD (Baethge et  al., 2003; Murray 
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and Harvey, 2010; Edgar and McClung, 2013; Geoffrey, 2014). 
The endogenous circadian system modulates mood and the 
sleep-wake cycle in mammals (Baethge et al., 2003; Murray and 
Harvey, 2010). The circadian system is a network of open feed-
back loops governed by the circadian pacemaker located in the 
hypothalamic suprachiasmatic nucleus and influenced by a 
number of inputs including exposure to light, arousal levels, and 
social and psychological cues (Harvey et al., 2011). Cells of the 
suprachiasmatic nucleus are themselves genetically regulated 
by transcriptional and posttranscriptional clock proteins (Azzi 
et al., 2014), and epigenetic mechanisms underlie the substan-
tial plasticity in circadian behavior (Stevenson and Prendergast, 
2013; Azzi et  al., 2014). Prospective data have shown that 
changes in sleep and circadian rhythm precede and predict the 
onset of mood episodes (depressive and manic) in BD patients 
(Bauer et al., 2008). Emotional regulation and circadian distur-
bances are associated with neurotransmitter systems (Lamont 
et al., 2007; McClung, 2007) and genes that are implicated in the 
etiology of BD (Mitterauer, 2000; Benedetti et al., 2007; McClung, 
2007; Harvey, 2008). Lithium and other maintenance treatments 
are known to stabilize circadian function (Klemfuss, 1992; Li 
et al., 2002; Yin et al., 2006), and circadian clock genes have been 
associated with response to lithium prophylaxis in BD patients 
(Rybakowski et al., 2014). Of specific relevance here is evidence 
that circadian disturbance persists during euthymic periods 
in remitted BD patients (Millar et al., 2004; Harvey et al., 2005; 
Geoffroy et al., 2014) and may be a trait marker and candidate 
endophenotype in high-risk children (Nurnberger et  al., 1988; 
Jones et al., 2006b; Ritter et al., 2012; Ng et al., 2015). Specifically, 
remitted BD patients have shown longer sleep latency, higher 
fragmentation index, lower sleep quality, and lower sleep effi-
ciency compared with controls (Geoffroy et  al., 2014). While 
most studies have been completed in BD adults, there is some 
evidence of differences in sleep patterns in high-risk compared 
with control offspring (Jones et al., 2006b) and in healthy indi-
viduals at behavioral risk (Ankers and Jones, 2009). Also, we have 
reported that sleep disorders are childhood antecedents predict-
ing an increased risk of mood disorders in high-risk offspring 
(Grof et al., 2009; Ritter et al., 2012; Duffy et al., 2014), consistent 
with the hypothesis that circadian disturbance is a vulnerability 
marker in youth at familial risk.
Chronic inflammation and dysregulation of the immune 
response is a known disease mechanism in a variety of disorders, 
including cancer, dementia, and more recently mood disorders. 
There is accruing evidence from clinical and animal studies of 
an association between mood episodes of both depressive and 
manic polarity and low-grade chronic inflammation (Raison 
and Miller, 2011; Leonard and Maes, 2012). Proinflammatory 
cytokines such as IL-1β, IL-6, and TNFα have been associated 
with depressive and anxious behavioral states when adminis-
tered both systemically and centrally in animals (Anisman et al., 
2005; Song et al., 2006; Song and Wang, 2011). Increased serum 
levels of these inflammatory mediators and acute phase pro-
teins have been associated with acute episodes of depression 
and mania in humans (Goldstein et al., 2009; Kauer-Sant’Anna 
et al., 2009; Song et al., 2009; Berk et al., 2011; Maes et al., 2012). 
Furthermore, markers of cell-mediated immune activation have 
been associated with depression (Maes, 2011; Maes et al., 2012) 
and BD (Munkholm et al., 2013).
Cytokines and other immune mediators directly and indi-
rectly access the brain and widely influence brain function. 
Cytokines interact with every pathophysiological domain impli-
cated in mood disorders. As reviewed by McClung (2013), mech-
anisms mediating the association between a proinflammatory 
state and mood disorders include circadian disturbance (Muller-
Oerlinghausen et  al., 2005), activation of the HPA axis (Raison 
and Miller, 2011), and modulation of monoamine neurotransmit-
ter systems (Felger and Lotrich, 2013). With progressive burden 
of illness, there is evidence of amplified changes in inflamma-
tory markers, increased oxidative stress, mitochondrial dys-
function, and decreased neurotrophic factors (Berk et al., 2011; 
Maes et  al., 2011; Fries et  al., 2012; Frey et  al., 2013). Lithium 
and other mood stabilizers regulate inflammatory mediators 
and circadian rhythm (Murray and Harvey, 2010), while several 
classes of antidepressants normalize the proinflammatory bias 
in treatment-responsive patients (Maes, 2001; Song et al., 2009; 
Berk et al., 2011; Raison et al., 2013).
Most studies of inflammatory markers have been cross-sec-
tional in nature and involved adult BD patients and are there-
fore confounded by substantial burden of illness effects. It is 
conceivable that recognizable differences in cytokine overactiv-
ity are present in high-risk individuals during the early stages 
of illness development. Padmos and colleagues (2008) reported 
increased expression of proinflammatory genes in remitted 
adults with BD and their high-risk offspring, especially in those 
who went on to develop depressive disorders. In a more recent 
cross-sectional analysis of prospectively assessed high-risk off-
spring, these authors reported evidence of increased inflam-
matory gene expression in monocytes during adolescence and 
early adulthood in high-risk offspring compared with controls 
(Mesman et al., 2015). Similarly, in a cross-sectional pilot study 
of prospectively assessed high-risk offspring, we reported evi-
dence of increased IL-6 and BDNF plasma protein levels in high-
risk offspring compared with controls and in high-risk offspring 
in the earlier compared with the later clinical stages of illness 
development (Duffy, 2014b). These associations were moderated 
by specific genetic variants.
Collectively, findings suggest that, for at least a subset 
of high-risk individuals, perturbations in the circadian and 
neuro-immune system influencing emotional functioning 
are promising candidate markers of vulnerability in high-risk 
youth associated with the subsequent onset of mood disorders 
(Maes, 2011; Insel, 2012; Raison and Miller, 2013; Ng et al., 2015). 
Furthermore, preliminary evidence suggests that changes in 
these markers parallel development and progression of mood 
disorders, and the strength of these associations may be influ-
enced by genetic variants (Duffy, 2014b).
Closing Remarks and Future Directions
BD is a multi-gene disorder, and it is becoming increasingly clear 
that in the majority of cases, identifying genetic variants asso-
ciated with increased susceptibility to BD is going to be insuf-
ficient to fully understand how those at familial risk develop 
illness. We now realize that genetic vulnerability may manifest 
in a variety of interactive pathways, including genetically deter-
mined sensitivity to early adversity, higher emotional reactivity 
to stress programmed during critical periods of development, 
unstable or vulnerable psychological processes and maladap-
tive coping styles that act both as risk and perpetuating factors, 
and through genetically mediated circadian and neuroendo-
crine pathways moderated by other risk exposures (Figure  2). 
Longitudinal studies of children at confirmed familial risk for 
developing BD provide an ideal approach to investigate these 
interactive processes at different stages of biological, psycho-
logical, and illness development, assessing both the individual 
and combined influences on risk and illness progression. The 
high-risk approach also provides the opportunity for identifying 
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and understanding factors that contribute to resiliency in the 
face of risk and which may not be simply the inverse of the iden-
tified risk factors (eg, low compared with high emotionality). 
Longitudinal high-risk studies have already provided substan-
tial evidence that BD is developing many years prior to the first 
diagnosable activated (ie, manic/hypomanic) episode and jeop-
ardizes normative emotional, psychological, social, and likely 
neurobiological development.
The proposed aggregate clinical staging model requires 
refinement based on systematic longitudinal studies of multi-
ple candidate vulnerability and illness progression markers in 
parallel in well-characterized high-risk offspring. This informa-
tion could inform a comprehensive risk model that takes into 
account genetically sensitive intermediate pathways, allowing 
for the placement of an individual on an illness continuum and 
refined monitoring of illness progression as routinely occurs 
in other areas of medicine (McGorry, 2013). Moreover, a fuller 
understanding of the important early exposures that interact 
with genetic risk and the psychological processes that mediate 
between genetic risk and mood disorder onset would provide 
the necessary basis for developing and refining targeted preven-
tion and early intervention strategies.
This review was limited in a number of important ways that 
should be mentioned. First, this was not intended to be a sys-
tematic review of the literature but rather a selective review of 
promising early intervention targets focusing on the findings 
from longitudinal prospective offspring studies. Findings from 
neuroimaging studies were not included in this review, as the 
practical application to early intervention is at this time not 
clear and beyond the scope of the paper. Second, the published 
studies discussed vary in terms of recruitment strategies, inclu-
sion and exclusion criteria, and methods of assessment, which 
can affect outcomes of interest and therefore should be kept in 
mind (Duffy et al., 2011).
Practical implications of the already available evidence sug-
gest that parents and parents-to-be suffering from BD should 
be provided with intensive medical, psychological, educational, 
and family support to ensure the best quality of remission, 
prevent postpartum recurrences, maintain stability of circadian 
rhythm, and facilitate healthy attachments with their newborn. 
Furthermore, children of BD parents should be monitored for 
early risk syndromes, including circadian disturbance, stress/
emotional reactivity, anxiety disorders, and psychological vul-
nerability (rumination, unstable self-esteem, impulsivity, and 
reward sensitivity/risk taking). Finally, there is sufficient evi-
dence to justify the development of specialized high-risk and 
early intervention programs that engage children and teenagers 
who are at identifiable (familial, clinical) increased risk of seri-
ous mood disorders and provide education about risk factors (ie, 
substance abuse), sleep regulation, optimal diet, healthy coping, 
exercise, and suitability for evidence-based step-wise interven-
tion as needed.
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